- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05197478
THE EFFECT OF LIFESTYLE ON THE PROGRESS OF COVID 19
LIFE STYLE BEFORE COVID 19 INFECTION IMPACT ON THE PROGRESS OF COVID 19
THE EFFECT OF LIFESTYLE ON THE PROGRESS OF COVID 19 INFECTION
The development of COVID 19 disease depends on the interaction with the immunity of the host. The immune response of the host is related to age, gender, nutrition, sleep and physical activity. Our study in Fatih Sultan Mehmet Training and Research Hospital; Between 31 January-31 May 2021,positive COVID 19 PCR test was performed with 66 patients over the age of 50, who received inpatient treatment. Demographic data of the patients, length of hospitalization, alcohol/tobacco use, BMI, comorbidities, regular use medication or not, thorax CT findings, place of discharge after treatment, laboratory parameters were recorded at hospitalization and discharge.
To evaluate the pre-infection lifestyle; physical activity, nutrition and sleep habits were questioned.
According to the PSQS (Pittsburg Sleep Quality Scale) although the increase in discharged lymphocyte measurements compared to the first hospitalization of the patients in the good and bad sleep groups was significant, there was no significant difference between the groups. In the evaluation between the groups, the increase in the NLR value at the first hospitalization was significant in the bad sleep group compared to the good sleep group. There was no difference between the groups in terms of NLR.
According to the MNA(Mini Nutritional Assessment)scale ;the increase in the discharge lymphocyte value of the groups compared to the value at the first hospitalization was significant. The increases in the discharge lymphocyte measurements of the patients compared to the first hospitalization were significant between the groups (p<0.05). The increase in discharge lymphocyte values in patients at risk of malnutrition compared to the first hospitalization was higher than in patients with malnutrition (p<0.05). The decrease in discharge NLR values compared to the first hospitalization was significant in the group under normal nutrition and malnutrition risk. The difference between the first hospitalization PLT (Platelet)measurements of the groups according to the MNA scale was significant.
According to the International Brief Physical Activity Survey; the increase in the discharge lymphocyte value of the inactive, minimally active and very active groups was significant compared to the first hospitalization. A significant difference was found between the PLT measurements between the groups (p<0.05). PLT measurements of very active cases were higher than those of minimally active cases (p<0.05).
In this study, in which we examined the effects of lifestyle before the diagnosis of COVID 19 on the course of COVID 19, we observed that there is no need for intensive care in patients who are well fed, have good sleep quality and are physically active.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Our study in Fatih Sultan Mehmet Training and Research Hospital; It was conducted prospectively on 31 January - 31 May 2021:
Inclusion criteria:
Patients over 50 years of age, Who were hospitalized in the pandemic ward Patients with positive COVID 19 pcr test and were taken into ethical examination (E-17073117-050.06)
Exclusion criteria:
Patients under 50 years of age, Patients with negative COVID 19 pcr test, Lymphatic system disease or malignant hematological diseases were excluded from the study.
Patient age, gender, education status,time spent at home before hospitalization ,duration of hospitalization, alcohol/tobacco use, body mass index,presence of thorax CT lesion ,whether the patients were discharged to another service, intensive care unit, or home after the treatment of COVID 19,laboratory findings at admission and discharge (lymphocyte level, neutrophil-lymphocyte ratio and platelet count at first admission) were recorded.
To evaluate the lifestyle before being infected with COVID 19, physical activity, nutrition and sleep habits were questioned.
To evaluate sleep habits; Pittsburg Sleep Quality Scale (PSQS) , Nutritional habits; Mini Nutritional Assessment(MNA) Scale, For the evaluation of physical activity; International Brief Physical Activity Questionnaire Done.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Istanbul, Turkey, 34734
- Yıldız
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
COVID 19 pcr test positive over 50 years of age, inpatient treatment patients with pandemic service received ethics committee approval
Exclusion Criteria:
COVID 19 pcr negative Under 50 years of age, Lymphatic system patients with disease or malignant hematological diseases
Study Plan
How is the study designed?
Design Details
- Primary Purpose: SUPPORTIVE_CARE
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
OTHER: COVID 19 positive patients
COVID 19 positive patients receiving inpatient treatment were evaluated.
|
To evaluate the lifestyle before being infected with COVID 19, physical activity, nutrition and sleep habits were questioned. To evaluate sleep habits; Pitsburg Sleep Quality Scale (PSQS) Nutritional habits: Mini Nutritional Assessment(MNA) Scale For the evaluation of physical activity; International Brief Physical Activity Questionnaire |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pittsburgh Sleep Quality Index (PSQI) .
Time Frame: UP TO 24 WEEKS
|
SLEEP QUALİTY SCALE The total PSQI score is obtained by summing the seven sub-scores. The total score ranges from 9 to 21. The PSQI total score clearly distinguishes good sleepers from bad sleepers. Good sleep:5 points or less Bad Sleep:over 5 points |
UP TO 24 WEEKS
|
|
Mini Nutritional Assessment
Time Frame: UP TO 24 WEEKS
|
NUTRITIONAL STATUS The sum of the MNA score distinguishes between elderly patients with:
Normal nutritional status:24-30 points At risk of malnutrition:17-23.5 Malnourished:under 17 points |
UP TO 24 WEEKS
|
|
International Short Physical Activıiy Questionnaire
Time Frame: UP TO 24 WEEKS
|
Category 1:INACTIVE It is the lowest level of physical activity. Conditions that cannot be included in categories 2 and 3 are considered inactive. Category 2:MINIMUM ACTIVE 2 a:Doing vigorous activity for at least 20 minutes on 3 or more days 2b:5 or more days of moderate-intensity activity or walking for at least 30 minutes a day 2c:A combination of 5 or more days of walking and moderate-intensity activity providing a minimum of 600 MET-min/week Category 3:VERY ACTIVE 3 a:At least 3 days of vigorous physical activity or more days providing a minimum of 1500 MET-min/week 3b:Moderate to vigorous walking for 7 days providing a minimum of 3000 MET-min/week combination of activity |
UP TO 24 WEEKS
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
LYMPHOCYTE COUNT
Time Frame: UP TO 24 WEEKS
|
HEMATOLOGICAL BIOMARKER
|
UP TO 24 WEEKS
|
|
NEUTROPHIL LYMPHOCYTE RATIO
Time Frame: UP TO 24 WEEKS
|
HEMATOLOGICAL BIOMARKER
|
UP TO 24 WEEKS
|
|
PLATELET COUNT
Time Frame: UP TO 24 WEEKS
|
HEMATOLOGICAL BIOMARKER
|
UP TO 24 WEEKS
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- yildizyigit1
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on COVID-19
-
PfizerActive, not recruitingCOVID-19 | Coronavirus Disease 2019 (COVID-19) | COVID-19 Infection | COVID-19 Vaccines | SARS-CoV-2 Infection, COVID19 | COVID-19 Vaccination | SARS-CoV-2 Infection, COVID-19 | COVID-19 (Coronavirus Disease 2019) | COVID-19 SARS-CoV-2 InfectionUnited States
-
Shanghai Public Health Clinical CenterNot yet recruiting
-
Duke UniversityNational Institute on Minority Health and Health Disparities (NIMHD)Completed
-
Eggensberger OHGBavarian Health and Food Safety Authority (LGL)RecruitingPost COVID-19 Condition | Post COVID-19 | Post COVID-19 Syndrome | Long COVID-19 Syndrome | Post COVID-19 Condition (PCC)Germany
-
PfizerRecruitingRespiratory Tract Diseases | COVID-19 | Pneumonia | Lung Diseases | Coronavirus Disease 2019 | Coronavirus Disease 2019 (COVID-19) | COVID-19 Infection | Upper Respiratory Tract Infections | Respiratory Tract Infection | COVID-19 (Coronavirus Disease 2019) | COVID-19 SARS-CoV-2 InfectionBelgium
-
ModeX Therapeutics, An OPKO Health CompanyRecruitingCOVID -19 | COVID-19 (Prevention)United States
-
Lawson Research Institute of St. Joseph'sCanadian Institutes of Health Research (CIHR); Western University, CanadaRecruitingFatigue | Post-COVID-19 Syndrome | Post COVID-19 Condition | Post-COVID Syndrome | Long COVID-19 | Long-COVID | Post-COVID ConditionCanada
-
University of Roma La SapienzaQueen Mary University of London; Università degli studi di Roma Foro Italico; Bios Prevention SrlCompletedPost Acute Sequelae of COVID-19 | Post COVID-19 Condition | Long-COVID | Chronic COVID-19 SyndromeItaly
-
Yang I. PachankisActive, not recruitingCOVID-19 Respiratory Infection | COVID-19 Stress Syndrome | COVID-19 Vaccine Adverse Reaction | COVID-19-Associated Thromboembolism | COVID-19 Post-Intensive Care Syndrome | COVID-19-Associated StrokeChina
-
University of Missouri, Kansas CityNational Institute on Minority Health and Health Disparities (NIMHD)Active, not recruitingCOVID-19 Testing BehaviorsUnited States
Clinical Trials on Mini Nutritional Assessment ,Pıtsburg Sleep Qualıty Scale, Short Physical Activity Survey
-
Cardiocentro TicinoCompletedPostoperative DeliriumSwitzerland
-
Halic UniversityCompletedSleep Initiation and Maintenance DisordersTurkey
-
Nigde Omer Halisdemir UniversityCompletedTeachers | PhysiotherapistTurkey (Türkiye)
-
Ankara Yildirim Beyazıt UniversityUnknownFatigue | Physical Activity | SleepTurkey
-
Brigham and Women's HospitalAnesthesia Patient Safety FoundationCompletedMild Cognitive ImpairmentUnited States
-
Istinye UniversityCompletedQuality of Life | Physical Activity | Sleep QualityTurkey
-
Washington University School of MedicineScaleDownCompleted
-
Konya Beyhekim Training and Research HospitalCompletedLow Back Pain | Cognitive DysfunctionTurkey
-
Ohio State UniversityCompleted
-
Saglik Bilimleri UniversitesiNot yet recruitingPes Planus